utsugisawa kimiaki 槍澤公明

… Alternative Names

槍澤公明ウツギサワキミアキ

UTSUGISAWA Kimiaki 槍澤公明

Less

Researcher Number	00244913
Other IDs
Affiliation (Current)	2025: 公益財団法人総合花巻病院(臨床研究部), 脳神経内科, 副院長
Affiliation (based on the past Project Information) *help	2021 – 2022: 公益財団法人総合花巻病院(臨床研究部), 脳神経内科, 脳神経内科部長 2017 – 2020: 公益財団法人総合花巻病院(臨床研究部), 神経内科, 神経内科部長 1998 – 2004: 岩手医科大学, 医学部, 講師 1995 – 1997: 岩手医科大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Neurology Except Principal Investigator Neurology / Neurology
Keywords	Principal Investigator Hypoxia / Cell cycle / PC12 / α7nAChR / CD44 / 胸腺 / 重症筋無力症 / Protein kinase Cδ / Neurite outgrowth / Extracellular-signal-regulated kinase … More / Angiotensin II / Neuronal damage / DNA fragmentation / Akt / tau / cyclin-dependent kinase 5 / p35 / extracellular-signal-regulated kianse / α7サブタイプ / ニコチン性アセチルコリン受容体 / Cell death / proten kinase C δ / candesartan / AT2 / AT1 / protein kinase Cδ / neurite outgrowth / cell cycle / hypoxia / ERK / angiotensin II / B7 / 再循環 / B7-1 / IL-2 / CD45RO / アナジー … More Except Principal Investigator aging / 老化 / α7nAChR / PC12 / neurite outgrowth / human brain / extracellular-signal-regulated kinase / cell cycle / cDNA array / ニューロン / tau / APP / RAGE / transcription / promoter / methylcytosines / メッセンジャーRNA / リスクファクター / 臨床疫学 / クリーゼ / 重症筋無力症 / リン酸化 / アセチルコリン受容体 / DNAアレイ / ERK / α7nAchR / 転写調節領域 / タウ蛋白 / アミロイド前駆体蛋白 / bisulfite法 / 加齢 / プロモーター領域 / メチルシトシン / 補体 / α7サブユニット / ニコチン性Ach受容体 / nicotinic acetyocholine receptor subunits(alpha4, beta2) / dopamine receptor (D_1, D_2) / nuclear receptors / molecular chaperone / selective vulnerability / neuron death / 海馬 / ニューロン死 / rt-PCR / D_1,S_2受容体 / 線条体 / ニコチン性アセチルコリン受容体 / 核内受容体 / D_1,D_2受容体 / ペプチド前駆物質 / 熱ショックタンパク / 選択的脆弱性 / 神経細胞死 Less

Attempt to elucidate the pathological mechanisms of myasthenic crisis
- Principal Investigator
  
  Murai Hiroyuki
- Project Period (FY)
  2017 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Neurology
- Research Institution
  International University of Health and Welfare
Effects of nicotinic acetylcholine receptor overexpression in neuronal cells.Principal Investigator
- Principal Investigator
  
  UTSUGISAWA Kimiaki
- Project Period (FY)
  2002 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Neurology
- Research Institution
  Iwate Medical University
Gene expression profile of aging human brain and its in vitro model
- Principal Investigator
  
  TOHGI Hideo
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Neurology
- Research Institution
  Iwate Medical University
重症筋無力症胸腺におけるリンパ球の再循環・活性化機構についてPrincipal Investigator
- Principal Investigator
  
  槍沢公明
- Project Period (FY)
  1998 – 1999
- Research Category
  
  Grant-in-Aid for Encouragement of Young Scientists (A)
- Research Field
  
  Neurology
- Research Institution
  Iwate Medical University
Changes with age in DNA methylation and transcription in human cerebral cortex.
- Principal Investigator
  
  TOHGI Hideo
- Project Period (FY)
  1998 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (B).
- Research Field
  
  Neurology
- Research Institution
  Iwate Medical University
重症筋無力症摘出胸腺組織におけるCD44発現亢進の意義Principal Investigator
- Principal Investigator
  
  槍沢公明
- Project Period (FY)
  1996
- Research Category
  
  Grant-in-Aid for Encouragement of Young Scientists (A)
- Research Field
  
  Neurology
- Research Institution
  Iwate Medical University
Selective Vulnerability of neurons in age-related neuronal death and its molecular mechanisms
- Principal Investigator
  
  TOHGI Hideo
- Project Period (FY)
  1995 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Neurology
- Research Institution
  Department of Neurology, Iwate Medical University

All 2022 2021 2020 2019 2018 2017 2005 2004 2003 2002

All Journal Article Presentation

[Journal Article] Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: Analysis of 1-year postmarketing surveillance.2022
- Author(s)
  Murai H, Suzuki S, Fukamizu Y, Osawa T, Kikui H, Utsugisawa K:
- Journal Title
  
  Clin Exp Neuroimmunol
  
  Volume: 13 Issue: 4 Pages: 280-289
- DOI
  10.1111/cen3.12716
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09780
[Journal Article] Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: Interim analysis of post-marketing surveillance2021
- Author(s)
  Murai H, Suzuki S, Hasebe M, Fukamizu Y, Rodrigues E, Utsugisawa K
- Journal Title
  
  Ther Adv Neurol Disord
  
  Volume: 14
- DOI
  10.1177/17562864211001995
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09780
[Journal Article] Zilucoplan: an investigational complement C5 inhibitor for the treatment of acetylcholine receptor autoantibody- positive generalized myasthenia gravis2021
- Author(s)
  Howard JF, Vissing J, Gilhus NE, Leite MI, Utsugisawa K, Duda PW, Farzaneh-Far R, Murai H, Wiendl H
- Journal Title
  
  Expert Opin Investig Drugs
  
  Volume: 30 Issue: 5 Pages: 483-493
- DOI
  10.1080/13543784.2021.1897567
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Journal Article] Efficacy, Safety, and Tolerability of Efgartigimod in Patients with Generalized Myasthenia Gravis (gMG): Analysis of the Randomized Phase 3 ADAPT Study2021
- Author(s)
  Howard JF, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R, ADAPT Investigator Study Group
- Journal Title
  
  Lancet Neurol
  
  Volume: 20 Issue: 7 Pages: 526-536
- DOI
  10.1016/s1474-4422(21)00159-9
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Journal Article] Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study2020
- Author(s)
  Jacob S, Murai H, Utsugisawa K, Nowak RJ, Wiendl H, Fujita KP, O’Brien F, Howard JF
- Journal Title
  
  Ther Adv Neurol Disord
  
  Volume: 13 Pages: 1-8
- DOI
  10.1177/1756286420911784
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Journal Article] Clinical burden and healthcare resource utilization associated with myasthenia gravis: assessments from a Japanese claims database2019
- Author(s)
  Murai H, Hasebe M, Murata A, Utsugisawa K
- Journal Title
  
  Clin Exp Neuroimmunol
  
  Volume: 10 Issue: 1 Pages: 61-68
- DOI
  10.1111/cen3.12495
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09780
[Journal Article] Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.2019
- Author(s)
  Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr; Regain
- Journal Title
  
  Muscle Nerve.
  
  Volume: - Issue: 1 Pages: 14-24
- DOI
  10.1002/mus.26447
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05279, KAKENHI-PROJECT-17K09780
[Journal Article] Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study2019
- Author(s)
  Murai H, Uzawa A, Suzuki Y, Imai T, Shiraishi H, Suzuki H, Okumura M, O’Brien F, Wang JJ, Fujita KP, Utsugisawa K
- Journal Title
  
  Journal of the Neurological Sciences
  
  Volume: 407 Pages: 116419-116419
- DOI
  10.1016/j.jns.2019.08.004
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Journal Article] Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan2018
- Author(s)
  Imai Tomihiro、Utsugisawa Kimiaki、Murai Hiroyuki、Tsuda Emiko、Nagane Yuriko、Suzuki Yasushi、Minami Naoya、Uzawa Akiyuki、Kawaguchi Naoki、Masuda Masayuki、Konno Shingo、Suzuki Hidekazu、Akaishi Tetsuya、Aoki Masashi
- Journal Title
  
  J Neurol Neurosurg Psychiatry
  
  Volume: in press Issue: 5 Pages: 513-517
- DOI
  10.1136/jnnp-2017-316625
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09691, KAKENHI-PROJECT-17K09780
[Journal Article] Rationale for the clinical guidelines for myasthenia gravis in Japan2018
- Author(s)
  Murai H, Utsugisawa K, Nagane Y, Suzuki S, Imai T, Motomura M
- Journal Title
  
  Annals of the New York Academy of Sciences
  
  Volume: 1413 Issue: 1 Pages: 35-40
- DOI
  10.1111/nyas.13544
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09780, KAKENHI-PROJECT-17K09787
[Journal Article] Efficacy of low-dose FK506 in the treatment of myasthenia gravis -A randomized pilot study-2005
- Author(s)
  Y.Nagane, K.Utsugisawa, D.Obara, R.Kondoh, Y.Terayama
- Journal Title
  
  Eur Neurol (in press)
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Candesartan prevents angiotensin II -induced facilitation of hypoxic neuronal damage through PKC δ inhibition.2005
- Author(s)
  K.Utsugisawa, Y.Nagane, T.Utsugisawa, D.Obara, Y.Terayama
- Journal Title
  
  Mol Brain Res in press
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Efficacy of low-dose FK506 in the treatment of myasthenia gravis-A randomized pilot study-2005
- Author(s)
  Y.Nagane, K.Utsugisawa, D.Obara, R.Kondoh, Y.Terayama
- Journal Title
  
  Eur Neurol in press
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Candesartan prevents angiotensin II-induced facilitation of hypoxic neuronal damage through PKC δ inhibition.2005
- Author(s)
  K.Utsugisawa, Y.Nagane, T.Utsugisawa, D.Obara, Y.Terayama.
- Journal Title
  
  Mol Brain Res (in press)
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Striatocapsular infarction caused by middle cerebral artery dissection.2004
- Author(s)
  R.Kondoh, K.Utsugisawa, D.Obara, M.Mizuno, H.Yonezawa, Y.Terayama.
- Journal Title
  
  Eur Neurol 51
  
  Pages: 120-121
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Striatocapsular infarction caused by middle cerebral artery dissection.2004
- Author(s)
  R.Kondoh, K.Utsugisawa, D.Obara, M.Mizuno, H.Yonezawa, Y.Terayama
- Journal Title
  
  Eur Neurol 51
  
  Pages: 120-121
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Candesartan prevents angiotensin II-induced facilitation of hypoxic neuronal damage through PKCδinhibition.2004
- Author(s)
  K.Utsugisawa, Y.Nagane, T.Utsugisawa, D.Obara, Y.Terayama.
- Journal Title
  
  Mol Brain Res (in press)
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Clinical characteristics and efficacy of FK506 in myasthenia gravis patients with high Interleukin-2 productivity in peripheral blood mononuclear cells.2004
- Author(s)
  K.Utsugisawa, Y.Nagane, Y.Terayama.
- Journal Title
  
  Neurology 62
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells.2003
- Author(s)
  Utsugisawa K, Nagane Y, Yonezawa H, Obara D, Kondoh R, Tohgi H
- Journal Title
  
  Muscle Nerve 27
  
  Pages: 245-248
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Interleukin-2 production by peripheral blood mononuclear cells from patients with myasthenia gravis.2003
- Author(s)
  Utsugisawa K, Nagane Y, Obara D, Kondoh R, Yonezawa H, Tohgi H
- Journal Title
  
  Fur Neurol 49
  
  Pages: 160-163
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis.2003
- Author(s)
  Nagane Y, Utsugisawa K, Obara D, Yamagata M, Tohgi H
- Journal Title
  
  Muscle Nerve 27
  
  Pages: 582-589
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Hypoxic condition interferes with phosphorylation of Akt atThr308 in cultured rat PC12 cells.2002
- Author(s)
  Obara D, Utsugisawa K, Nagane Y, Tohgi H
- Journal Title
  
  Neurosci Lett 332
  
  Pages: 167-170
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Over-expression of α7 nicotinic acetyicholine receptor induces sustained ERK phosphorylation and N-cadherin expression in PC12 cells.2002
- Author(s)
  Utsugisawa K, Nagane Y, Obara D, Toligi H
- Journal Title
  
  Mol Brain Res 106
  
  Pages: 88-93
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] The Effect of Combined Therapy with Immunoadsorption andHigh-Dose Intravenous Methyiprednisolone on Myasthenia Gravis.2002
- Author(s)
  Munakata R, Utsugisawa K, Nagane Y, Yamagata M, Oikawa M, Obara D, Tohgi H
- Journal Title
  
  Eur Neurol 48
  
  Pages: 115-117
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Over-expression of α7 nicotinic acetyicholine receptor preventsGi-arrest and DNA fragmentation in PC12 cells after hypoxia.2002
- Author(s)
  Utsugisawa K, Nagane Y, Obara D, Tohgi H
- Journal Title
  
  J Neurochem 81
  
  Pages: 497-505
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Over-expression of α7 nicotinic acetylcholine receptor induces sustained ERK phosphorylation and N-cadherin expression in PC12 cells.2002
- Author(s)
  Utsugisawa K, Nagane Y, Obara D, Tohgi H
- Journal Title
  
  Mol Brain Res 106
  
  Pages: 88-93
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Over-expression of α7 nicotinic acetylcholine receptor prevents G1-arrest and DNA fragmentation in PC12 cells after hypoxia.2002
- Author(s)
  Utsugisawa K, Nagane Y, Obara D, Tohgi H
- Journal Title
  
  J Neurochem 81
  
  Pages: 497-505
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Journal Article] Hypoxic condition interferes with phosphorylation of Akt at Thr^<308> in cultured rat PC12 cells.2002
- Author(s)
  Obara D, Utsugisawa K, Nagane Y, Tohgi H
- Journal Title
  
  Neurosci Lett 332
  
  Pages: 167-170
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14570614
[Presentation] Long-Term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study2022
- Author(s)
  Meisel A, Bril V, Vu T, Karam C, Peric S, De Bleecker JL, Murai H, Beydoun S, Pasnoor M, Guglietta A, Ulrichts P, T’joen C, Utsugisawa K, Verschuuren J, Mantegazza R, Howard JF:
- Organizer
  8th Congress of the European Academy of Neurology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Efficacy of Efgartigimod in Generalized Myasthenia Gravis: Myasthenia Gravis Composite Score Analysis From ADAPT.2022
- Author(s)
  De Bleecker JL, Meisel A, Howard JF, Vu T, Bril V, Ulrichts P, Guglietta A, T’joen C, Murai H, Utsugisawa K, Mantegazza R:
- Organizer
  17th International Congress on Neuromuscular Diseases
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Real-world effectiveness of eculizumab in generalized myasthenia gravis in Japan: 1-year post-marketing surveillance data2022
- Author(s)
  Murai H, Suzuki S, Fukamizu Y, Osawa T, Kikui H, Utsugisawa K:
- Organizer
  第63回日本神経学会学術大会
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study.2022
- Author(s)
  Howard JF, Bril V, Vu T, Karam C, Peric S, De Bleecker JL, Murai H, Meisel A, Beydoun S, Pasnoor M, Guglietta A, Ulrichts P, T’joen C, Utsugisawa K, Verschuuren J, Mantegazza R:
- Organizer
  74th Annual Meeting of American Academy of Neurology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Analysis of Efgartigimod Efficacy Across Patient Populations and Myasthenia Gravis Specific Scales2021
- Author(s)
  Murai H, Bril V, Vu T, Karam C, Peric S, Imai T, Takahashi M, Uzawa A, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Mantegazza R, Howard J
- Organizer
  第62回日本神経学会学術大会
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] 日本におけるエクリズマブの全身型重症筋無力症に関する製造販売後調査の中間解析2020
- Author(s)
  村井弘之、鈴木重明、長谷部美紀、深水裕二、ロドリゲスエマ、槍澤公明
- Organizer
  第61回日本神経学会学術大会
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Safety and effectiveness of eculizumab for patients with generalized myasthenia gravis in Japan: Interim analysis of post-marketing surveillance2020
- Author(s)
  Murai H, Suzuki S, Hasebe M, Fukamizu Y, Rodriguez E, Utsugisawa K
- Organizer
  The 6th European Academy of Neurology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Response to eculizumab in patients with myasthenia gravis recently treated with chronic intravenous immunoglobulin2019
- Author(s)
  Genge A, Jacob S, Murai H, Utsugisawa K, Nowak RJ, Wiendl H, Fujita KP, O’Brien F, Howard JF
- Organizer
  The 54th Canadian Neurological Sciences Federation Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Relieving the burden of myasthenia gravis: eculizumab reduces exacerbation, hospitalization and rescue therapy rates2019
- Author(s)
  Siddiqi Z, Howard JF, Jacob S, Guptill JT, Meisel A, Wiendl H, Murai H, Utsugisawa K, Nowak RJ, Fujita KP, O’Brien F, Patra K, Muppidi S
- Organizer
  The 54th Canadian Neurological Sciences Federation Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Response to eculizumab in patients with AChR+ refractory myasthenia gravis recently treated with chronic IVIg2018
- Author(s)
  Jacob S, Murai H, Utsugisawa K, Nowak RJ, Wiendl H, Fujita KP, O’Brien F, Howard JF
- Organizer
  The 15th International Congress on Neuromuscular Diseases
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Open label extension trial of REGAIN to evaluate the safety and efficacy of eculizumab in patients from Japan with refractory generalized myasthenia gravis2017
- Author(s)
  Murai H, Uzawa A, Suzuki Y, Imai T, Shiraishi H, Tsuda E, Suzuki H, Okumura M, Utsugisawa K
- Organizer
  The 23rd World Congress of Neurology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780
[Presentation] Early fast-acting treatment strategy against generalized myasthenia gravis2017
- Author(s)
  Utsugisawa K, Nagane Y, Akaishi T, Suzuki Y, Imai T, Tsuda E, Minami N, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Murai H, Aoki M
- Organizer
  The 23rd World Congress of Neurology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09780

1. ABE Takashi (30202667)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
2. TOHGI Hideo (90155490)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
3. TAKAHASHI Satoshi (50216719)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
4. NAGANE Yuriko (10306003)

# of Collaborated Projects: 3 results

# of Collaborated Products: 16 results
5. YAMAGATA Munehisa (00295974)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
6. Murai Hiroyuki (80325464)

# of Collaborated Projects: 1 results

# of Collaborated Products: 20 results
7. 松下拓也 (00533001)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 今井富裕 (40231162)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
9. 本村政勝 (70244093)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. UZAWA Akiyuki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
11. 藤井博匡

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

utsugisawa kimiaki 槍澤 公明

槍澤 公明 ウツギサワ キミアキ

UTSUGISAWA Kimiaki 槍澤 公明

Research Projects

Research Products

Co-Researchers

Attempt to elucidate the pathological mechanisms of myasthenic crisis

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Effects of nicotinic acetylcholine receptor overexpression in neuronal cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Gene expression profile of aging human brain and its in vitro model

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

重症筋無力症胸腺におけるリンパ球の再循環・活性化機構についてPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Changes with age in DNA methylation and transcription in human cerebral cortex.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

重症筋無力症摘出胸腺組織におけるCD44発現亢進の意義Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Selective Vulnerability of neurons in age-related neuronal death and its molecular mechanisms

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: Analysis of 1-year postmarketing surveillance.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: Interim analysis of post-marketing surveillance2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Zilucoplan: an investigational complement C5 inhibitor for the treatment of acetylcholine receptor autoantibody- positive generalized myasthenia gravis2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy, Safety, and Tolerability of Efgartigimod in Patients with Generalized Myasthenia Gravis (gMG): Analysis of the Randomized Phase 3 ADAPT Study2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical burden and healthcare resource utilization associated with myasthenia gravis: assessments from a Japanese claims database2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.2019

Author(s)

utsugisawa kimiaki 槍澤公明

槍澤公明ウツギサワキミアキ

UTSUGISAWA Kimiaki 槍澤公明